Impact of hormone-therapy used in CRPC patients: Evaluation of abiraterone acetate/prednisone or enzalutamide on activity and cognitive functions in aged castrated mice

Hélène Castel (1) , T Al Sagheer (1) , Martine Dubois (1) , Cynthia Campart (1) , Laurence Desrues (1) , Marie Lange (2) , Pierrick Gandolfo (1) , Florence Joly (2)

1 DC2N - Différenciation et communication neuronale et neuroendocrine
2 UNICANCER/CRLC - Centre Régional de Lutte contre le Cancer François Baclesse [Caen]

Domaines: Sciences du Vivant [q-bio]

Hélène Castel, T Al Sagheer, Martine Dubois, Cynthia Campart, Laurence Desrues, et al.. Impact of hormone-therapy used in CRPC patients: Evaluation of abiraterone acetate/prednisone or enzalutamide on activity and cognitive functions in aged castrated mice. 2019 ASCO annual meeting, May 2019, Chicago, United States. ⟨hal-02294639⟩